The study showed that 45 percent of individuals who received the 90 microgram, two-dose regimen developed antibodies at a level that is expected to reduce the risk of getting influenza.

• 研究表明，接受两次90毫克给药方案的个体中有45%25产生了预期的降低罹患流感风险水平的抗体。